We are live on ! Find out more
CASM

CAS Medical Systems, Inc.
CASM

Delisted

CASM was delisted on the 18th of April, 2019.

32 hedge funds and large institutions have $21.7M invested in CAS Medical Systems, Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

67% more capital invested

Capital invested by funds: $13M → $21.7M (+$8.72M)

33% more funds holding

Funds holding: 2432 (+8)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
32
Holders Change
+8
Holders Change %
+33.33%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
5
Reduced
7
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ACP
1
Acuta Capital Partners
California
$12.8M
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.02M +$514K +239,222 +40%
Renaissance Technologies
3
Renaissance Technologies
New York
$1.65M +$65.2K +30,300 +5%
HCMT
4
Highland Capital Management (Texas)
Texas
$1.16M +$1.03M +478,000 New
ISL
5
Ingalls & Snyder LLC
New York
$713K -$373K -173,536 -37%
HighTower Advisors
6
HighTower Advisors
Illinois
$549K -$32.3K -15,000 -6%
SAM
7
SignalPoint Asset Management
Missouri
$457K +$5.13K +2,388 New
Envestnet Asset Management
8
Envestnet Asset Management
Illinois
$425K +$376K +175,000 New
Deutsche Bank
9
Deutsche Bank
Germany
$291K +$74K +34,400 +40%
Tudor Investment Corp
10
Tudor Investment Corp
Connecticut
$275K +$243K +113,216 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$265K +$171K +79,511 +266%
BlackRock
12
BlackRock
New York
$205K -$7.89K -3,669 -4%
Goldman Sachs
13
Goldman Sachs
New York
$203K +$179K +83,378 New
Northern Trust
14
Northern Trust
Illinois
$136K +$53.8K +25,016 +81%
Citadel Advisors
15
Citadel Advisors
Florida
$111K +$98.3K +45,708 New
HM
16
Harvest Management
New York
$76K +$67.1K +31,221 New
GCIA
17
Gabelli & Co Investment Advisers
New York
$61K +$53.8K +25,000 New
FM
18
Family Management
New York
$53K
Charles Schwab
19
Charles Schwab
California
$45K +$39.8K +18,487 New
VF
20
Virtu Financial
New York
$42K +$37.4K +17,411 New
Cambridge Investment Research Advisors
21
Cambridge Investment Research Advisors
Iowa
$30K +$26.2K +12,200 New
PM
22
Penbrook Management
New York
$27K -$24.1K -11,200 -50%
TI
23
Telemetry Investments
New York
$27K +$24.3K +11,280 New
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$25K
ASN
25
Advisory Services Network
Georgia
$10K

CASM Hedge Fund Activity: Q1 2019 in Review

32 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems, Inc. (CASM) for Q1 2019, worth a combined $21.7M — up 67% from $13M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CASM positions and 5 closed out — a net gain of 8 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Highland Capital Management (Texas), opening a new position worth an estimated $1.03M. The largest seller was EAM Investors, exiting entirely with an estimated $642K sold.

  • 32 institutional investors held CAS Medical Systems, Inc. (CASM) as of Q1 2019, up from 24 in Q4 2018.
  • Funds reported $21.7M of CAS Medical Systems, Inc. stock for Q1 2019, up 67% quarter-over-quarter.
  • 13 funds opened new CAS Medical Systems, Inc. positions in Q1 2019 and 5 closed out, a net change of +8 holders.
  • The largest CAS Medical Systems, Inc. buyer in Q1 2019 was Highland Capital Management (Texas), an estimated $1.03M added.
  • The largest CAS Medical Systems, Inc. seller in Q1 2019 was EAM Investors, an estimated $642K sold.

Based on aggregated 13F filings for Q1 2019.